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suckling piglet model was used to study nutritional and pharmaco-
logic means of stimulating hepatic fatty acid -oxidation. Newborn
pigs were fed milk diets containing either long- or medium-chain
triglycerides (LCT or MCT). The long-chain control diet was supple-
mented further with cloﬁbric acid (0.5%) or isoproterenol (40 ppm),
and growth was monitored for 10–12 days. Cloﬁbrate increased rates
of hepatic peroxisomal and mitochondrial -oxidation of [1-14C]-
palmitate by 60 and 186%, respectively. Furthermore, malonyl-CoA
sensitive carnitine palmitoyltransferase (CPT I) activity increased
64% (P  0.05) in pigs receiving cloﬁbrate. Increased CPT I activity
was not congruent with changes in message, as elevated abundance of
CPT I mRNA was not detected (P  0.16) when assessed by
qRT-PCR. Neither rates of -oxidation nor CPT activities were
affected by dietary MCT or by isoproterenol treatment (P  0.1).
Collectively, these ﬁndings indicate that cloﬁbrate effectively induced
hepatic CPT activity concomitant with increased fatty acid -oxidation.
acyl-CoA oxidase; fatty acid oxidase; malonyl-CoA; peroxisome;
peroxisome proliferator-activated receptor
DURING THE TRANSITION FROM intrauterine to extrauterine life,
survival of the young hinges on upregulation of the enzymes
required to promote efﬁcient use of fatty acids postpartum.
Although the primary energy source for the developing fetus is
maternal glucose, milk lipids become the principal source of
energy for postnatal growth and development (13). In support
of the changing nutrient environment, many neonates, includ-
ing rats, rabbits, and humans exhibit increased -oxidative
capacity, resulting in pronounced hyperketonemia (10, 13, 43).
However, piglets do not show an appreciable accumulation of
circulating ketone bodies during the suckling period (1, 7, 38),
and examination of fatty acid metabolism in cultured porcine
hepatocytes demonstrates a propensity toward fatty acid rees-
teriﬁcation with limited ﬂux through the pathway of -oxida-
tion (39). Why the piglet deviates from the accepted model of
hepatic lipid metabolism in the young is not known. However,
the demand for energy after birth necessitates an understanding
of the etiology of attenuated hepatic -oxidation in the piglet
for improving neonatal survival, as 55–60% of the energy for
the newborn is derived from milk fatty acids (13).
It is well established that the carnitine palmitoyltransferase
(CPT) system plays an essential role in regulating fatty acid
ﬂux through the pathway of -oxidation (27). Most notably,
CPT I and its regulation by malonyl-CoA governs the translo-
cation of activated fatty acids into the mitochondria for sub-
sequent -oxidation. Data collected in neonatal pigs suggest
that CPT I may contribute to the reduced rate of hepatic
-oxidation noted in this species (33, 35). Although CPT
activity doubles between birth and 1 day of age, the activity
measured at 1 day of age is equivalent to that measured at 24
days of age (5), inferring that activity expeditiously increases
postpartum before it plateaus after the ﬁrst day of life. How-
ever, fatty acid oxidation in the 1-day-old pig is only one-third
of the rate determined for the 24-day-old pig (5). This discrep-
ancy between CPT activity and fatty acid oxidation may be
explained by enhanced sensitivity of CPT I to malonyl-CoA.
Studies examining tissue speciﬁc CPT activity suggest that
unlike most other mammals, hepatic CPT I in the neonatal pig
is more sensitive to the inhibitory effects of malonyl-CoA (33).
The high degree of sensitivity for piglet hepatic CPT I is
reﬂected in hepatic concentrations of malonyl-CoA, which are
94% lower than rat liver concentrations (11). However, piglet
CPT I maintains its high degree of sensitivity to malonyl-CoA
under various physiological states (11, 44), whereas in the
rodent, sensitivity to malonyl-CoA is decreased under physio-
logical changes that elevate circulating fatty acids (40).
As part of an ongoing research effort to understand the basis
of low hepatic -oxidation in the young pig and the role of
CPT I, the objectives of the study were to determine whether
dietary intervention with cloﬁbrate, medium-chain triglycer-
ides (MCT), or isoproterenol would enhance hepatic -oxida-
tion and CPT activity. Cloﬁbrate, a peroxisomal proliferator,
has been shown to increase total (malonyl-CoA sensitive and
insensitive) CPT activity in neonatal pigs; however, its effects
on CPT I activity and mRNA abundance are not known. In
addition, stimulation of peroxisomal oxidation, which has been
shown to occur in piglets after cloﬁbrate administration (50),
provides an ancillary route for the oxidation of fatty acids,
which may bypass CPT I regulation of mitochondrial -oxi-
Address for reprint requests and other correspondence: Jack Odle, Dept. of
Animal Science, Box 7621, Raleigh, NC 27695 (E-mail: jack_odle@ncsu.edu).
The costs of publication of this article were defrayed in part by the payment
of page charges. The article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Am J Physiol Regul Integr Comp Physiol 288: R1518–R1524, 2005.
First published February 24, 2005; doi:10.1152/ajpregu.00822.2004.
0363-6119/05 $8.00 Copyright © 2005 the American Physiological Society http://www.ajpregu.org R1518dation. Second, MCT were fed to assess the response to a fatty
acid energy source, which is not reliant on CPT I for mito-
chondrial -oxidation (36). Third, it was hypothesized that the
antilipogenic effects of isoproterenol (41) may reciprocally
promote -oxidation. The study presented here illustrates that
hepatic -oxidation can be enhanced, concomitant with in-
creased CPT I activity after cloﬁbrate supplementation, and is
the ﬁrst to report the effects of isoproterenol on hepatic fatty
acid oxidation in neonatal pigs. Research centered on improv-
ing -oxidation in the young pig may help to elucidate nutri-
tional strategies to reduce neonatal morbidity and mortality in
this species, while also providing information on an animal
model of interest to biomedical research.
MATERIALS AND METHODS
Animals and diets. Procedures for this study were approved by the
North Carolina State University Animal Care and Use Committee.
Piglets were obtained from North Carolina State University Swine
Education Unit within 24–48 h after birth (suckled). Piglets were
individually housed in an environmentally controlled (30°C) facility
and allotted by gender and weight to one of four dietary treatments: 1)
control milk replacer with soybean oil as the lipid source and formu-
lated to contain 21% fat, 32% crude protein, and 34% lactose; 2)
control milk replacer supplemented with 0.5% (wt/wt) cloﬁbrate; 3)
control milk replacer with MCT source replacing 95% of soybean oil;
and 4) control milk replacer supplemented with 40 ppm isoproterenol.
Milk replacer was reconstituted with water to 15% (wt/vol) dry matter
and fed via gravity ﬂow through a nipple. Milk replacer was mixed
and replaced twice daily to maintain freshness, and dietary treatments
were fed for 10–12 days. Additional suckled piglets (24–48 h of age)
were euthanized at time of removal from dam to obtain data in the
newborn.
Reagents and chemicals. L-[N-Methyl-3H]carnitine (2.5 GBq/mol),
[1-14C]-palmitate (2.0 GBq/mmol), and [1-14C]-glucose (2.0 GBq/
mmol) were purchased from American Radiolabeled Chemicals (St.
Louis, MO). Palmitoyl-CoA, antimycin A, rotenone, and other chem-
icals were purchased from Sigma Chemicals (St. Louis, MO). Scin-
tillation ﬂuid (Scintisafe) was purchased from Fisher Scientiﬁc (St.
Louis, MO).
Collection of tissue samples. Pigs were euthanized via American
Veterinary Medical Association approved electrocution and had ac-
cess to feed before euthanasia. Liver and a portion of muscle (semi-
tendonosis) tissue were excised immediately. Liver was weighed, and
a portion was placed in ice-cold isolation buffer containing (in
mmol/l) 220 mannitol, 70 sucrose, 2 HEPES, and 0.1 EDTA (pH 7.4).
Liver was blotted, minced, and manually homogenized in 10 volumes
of the isolation buffer using a Potter-Elvejhem homogenizer. Homog-
enate and mitochondrial fractions were obtained by differential cen-
trifugation (29). Respiratory control ratios were determined on the
mitochondrial fraction to assess mitochondrial integrity (2). Protein
was determined by the biuret method (15) in both the homogenate and
mitochondrial fractions. Additional samples of liver and muscle were
frozen immediately in liquid nitrogen and stored at 80°C.
Analysis of carnitine palmitoyltransferase-I activity. Liver mito-
chondria were used to assess CPT activity as previously described by
Bremer (7). The assay measured the rate of formation of palmitoyl-
carnitine from palmitoyl-CoA and carnitine. The reaction medium
contained 75 mmol/l KCL, 50 mmol/l HEPES, 0.2 mmol/l EGTA, 1%
fatty acid free bovine albumin, and 80 mol/l of palmitoyl-CoA for
determination of total CPT activity. Activity of CPT was further
assessed as malonyl-CoA-sensitive or insensitive activity. Malonyl-
CoA-insensitive activity was determined by the addition of 250
mol/l of malonyl-CoA to the reaction medium. Malonyl-CoA-sen-
sitive CPT activity was determined as the difference between total
activity and malonyl-CoA-insensitive activity and representative of
CPT I activity. Reactions were initiated by the addition of 1 mmol/l of
L-[N-methyl-3H]-carnitine (0.05 Ci/reaction), and terminated by the
addition of 6% HClO4 after 6 min. The labeled palmitoyl-carnitine
was extracted with butanol and quantiﬁed by liquid scintillation
spectrometry.
Assays of mitochondrial and peroxisomal -oxidation. Rates of
ﬁrst-cycle total, mitochondrial, and peroxisomal -oxidation of
[1-14C] palmitate and oxidation of [1-14C] glucose were measured in
liver homogenates by a modiﬁcation of the procedures as previously
described (48). In duplicate reactions, aliquots of homogenate (300
l) were added to Erlenmeyer ﬂasks containing 1.7 ml of a reaction
medium (in mmol/l): 50 sucrose, 150 TrisHCl, 20 KH2PO4,1 0
MgCl26H2O, 2 EDTA, 1 L-carnitine, 0.2 CoA, 2 NAD, 0.1 malate,
10 ATP (pH 7.4). The reaction medium contained either: 1) [1-14C]-
palmitate, 2) [1-14C]-glucose, 3) [1-14C]-palmitate plus antimycin/
rotenone, 4) [1-14C]-palmitate plus glucose, or 5) [1-14C]-glucose plus
palmitate. Each reaction contained 0.5 Ci of either [1-14C]-palmitate
or [1-14C]-glucose. Palmitate was added to the reaction medium as
Na-palmitate bound to fatty acid-free albumin (complexed in a 5:1
molar ratio) to a ﬁnal concentration of 1 mmol/l. Glucose was added
to the reaction medium to achieve a ﬁnal concentration of 5 mmol/l.
Antimycin (50 mol/l) and rotenone (10 mol/l) were added to
inhibit mitochondrial oxidation for indirect determination of peroxi-
somal oxidation.
Reactions were initiated by the addition of the homogenate and
allowed to proceed for 30 min in a shaking water bath at 37°C.
Incubations were terminated by the addition of 1 ml of 3 mol/l HClO4
to the reaction medium. After termination of the reaction, ﬂasks were
incubated at room temperature (2 h) for collection of 14CO2 into a
suspended well containing 500 l of ethanolamine. When [1-14C]-
palmitate was contained in the reaction medium, acid-soluble products
(ASP) were collected following centrifugation of ﬂask contents to
precipitate protein and nonmetabolized palmitate. Blanks were pre-
pared by immediate acidiﬁcation of the reaction medium after the
addition of the homogenate. Radioactivity in CO2 and ASP was
quantiﬁed by liquid scintillation spectrometry.
The rate of total -oxidation was measured as the rate of accumu-
lation of 14Ci n14CO2 plus [14C-]ASP. The rate of accumulation of
14C into [14C-] ASP after the addition of the inhibitors antimycin and
rotenone was reported as peroxisomal -oxidation. Negligible 14CO2
production was measured in the presence of the inhibitors (data not
shown). Mitochondrial -oxidation was calculated to be the difference
between total -oxidation and peroxisomal -oxidation.
Extraction of total RNA. Total RNA was extracted from liver and
muscle tissue using guanidine isothiocyanate and phenol (TRI Re-
agent solution; Sigma-Aldrich,). Brieﬂy, tissue was homogenized (0.1
g tissue/ml TRI Reagent), and 0.2 ml of chloroform (per 1 ml TRI
Reagent) was added to the homogenate. After centrifugation (12,000
g, 15 min), the RNA was precipitated from the aqueous phase by the
addition of isopropanol (0.5 ml/ml TRI Reagent) followed by centrif-
ugation (12,000 g, 10 min). The resulting pellet was washed with 75%
ethanol and resuspended in RNase-free water. Gel electrophoresis
with ethidium bromide staining was used to assess RNA integrity. The
RNA was quantiﬁed and purity assessed by UV spectrophotometric
analysis of A260 and A260/A280 ratio (1.7), respectively.
Reverse transcription. The RNA (10 g/50 l) was treated with 4
units of TurboDNase (Ambion, Austin, TX), according to the manu-
facturer’s instructions for removal of genomic DNA. Phenol:chloro-
form extraction was used to recover the RNA, and 2 g was reverse-
transcribed using Omniscript reverse-transcription kit, according to
the manufacturer’s instructions (Qiagen, Valencia, CA). First-strand
cDNA was synthesized at 42°C for 60 min by priming with oligo-dT
(Roche Diagnostics, Basel, Switzerland). A negative control (using
pooled RNA) containing all of the reverse-transcription reagents in
the absence of RT enzyme was included to verify absence of genomic
DNA during PCR (no RT control).
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Select (DNAstar) was used to design pig-speciﬁc primers for hypo-
xanthine phosphoribosyltransferase (HPRT), CPT I (liver and skeletal
muscle isotypes), and acyl-CoA oxidase (ACO) (Table 1). Primer
pairs were selected for optimum annealing temperatures and negligi-
ble secondary structure. Primers were purchased through Sigma-
Genosys, and resuspended in 1  Tris/EDTA. The PCR aplicons were
sequenced to verify primer accuracy and speciﬁcity.
Real-time RT-PCR with SYBR Green. Real-time RT-PCR was
performed using the DNA Engine Opticon (MJ Research,). Real-time
ﬂuorescence detection was performed in 96-well plates using Quan-
titect SYBR Green buffer (Qiagen). Samples were assayed in tripli-
cate. Each 20-l reaction contained cDNA (equivalent to 100-ng
RNA) and 0.3 M each of the forward and reverse primers. After the
initial 15-min. incubation at 95°C for activation of the Hot Start Taq
DNA polymerase, all templates were ampliﬁed for 40 cycles using the
following protocol: denaturation for 15 s at 94°C, primer annealing for
30 s at 60°C, and elongation for 30 s at 72°C. Fluorescence data were
acquired at the end of each elongation phase. After the ampliﬁcation
program, melting curves were generated by measuring the ﬂuores-
cence as the temperature was raised from 50°C to 95°C in 0.2°C
increments to verify speciﬁcity of ﬂuorescence detection. Speciﬁcity
of ampliﬁcation products was further veriﬁed by gel electrophoresis
and ethidium bromide staining. Background ﬂuorescence was set as
the average ﬂuorescence between cycles 3 and 15, and cycle threshold
(Ct) was determined on the basis of 10 SD above background
ﬂuorescence (14). Positive (no template reaction) and negative (no
reverse transcriptase) controls were run in triplicate and included in
each PCR assay.
Analysis of real-time RT-PCR data. Standard curves for the refer-
ence gene HPRT and the target genes of interest for liver (LCPT I and
ACO) and muscle (MCPT I) were generated from pooled cDNA
(equivalent to 200, 100, 50, 25, and 12.5 ng of total RNA). The Ct
values were regressed on the log of template cDNA concentration.
The quality of the standard curves was assessed according to the
correlation coefﬁcient (r2  0.95), and the slope of the lines were used
to determine efﬁciency of ampliﬁcation according to the equation E 
101/slope (42; Fig. 1, Table 2). Because of unequal ampliﬁcation
efﬁciencies between the reference gene and target genes, a relative
expression ratio indicating fold change was determined according to
the method by Pfafﬂ (42) for assessment of treatment differences:
Expression Ratio 

	Ct
target

	Ct
reference
where 	Ct  sample  control for the target gene and reference gene.
Differences in Ct values for pigs fed cloﬁbrate (sample) were assessed
against Ct values obtained from control pigs for HPRT and the target
genes of interest (LCPT I, MCPT I, or ACO) to determine 	Ct values.
The 	Ct was used to determine abundance of mRNA using the
efﬁciency of ampliﬁcation for target genes and the reference gene.
The target gene was corrected for differences in reference gene
ampliﬁcation to obtain the expression ratio. Variance of the expres-
sion ratio was determined according to Marino and colleagues (26):
VariancelnR 
sCt1
 
2

sCt2
 
2


Ct2  Ct1 s

2 
2
where Ct1  sample, Ct2  control and sCt1 and sCt2  estimate of
SE (average of triplicate readings) for the sample and control (respec-
tively), slope of the gene being evaluated and s  error of the
slope. Log variance was determined for the target genes and the
reference gene. Target gene variance was corrected for differences in
the reference gene using the following equation:
corrected variancelnR  variancelnRTarget  variancelnReference
The corrected variance was linearized and the SE determined.
Statistical analysis. Data were subjected to ANOVA using the
general linear models procedure of SAS (SAS, Cary, NC) appropriate
for a completely randomized design (CRD). Initial body weight was
used as a covariate in analysis of growth parameters. Effects of
substrate (palmitate or glucose) oxidation were analyzed as a subplot
within the CRD. A one-sided Student’s t-test was used for determin-
ing signiﬁcance in fold change of hepatic ACO and LCPT I, and
MCPT I expression for cloﬁbrate supplementation relative to control.
RESULTS
At the end of the treatment period control, cloﬁbrate, MCT,
and isoproterenol-supplemented pigs weighed 5138 g (135),
Table 1. Primers used for ampliﬁcation of HPRT, LCPT I,
MCPT I, and ACO and expected amplicon size following
SYBR Green RT-PCR
Gene Primer sequence (5 3 3)
Amplicon
Size, bp Accession*
HPRT F: CCATCACATCGTAGCCCTCTG 172 AF143818
R: TACTTTTATATCGCCCGTTGACTG
L CPT I F: GGACCGCCACCTGTTCTGCCTCTA 175 AF288789
R: GCCCCCTCCGCTCGACACATAC
M CPT I F: GCACGCCAGGCCTTCTTCAGC 121 AY181062
R: TGGCCTCGTCTTCCGGGTCATAGT
ACO F: ACCACGGTGAAGAAGATAAGG 181 AF185048
R: TCCAGGCGGGCATGAAGAAGC
*Accession numbers listed reference published GenBank pig-speciﬁc se-
quences that were used to design forward and reverse primers. HPRT, hypo-
xanthine phosphoribosyltransferase; LCPT I, liver isotype of carnithine palmi-
toyltransferase I; MCPT I, skeletal muscle isotype of carnitine palmitoyltrans-
ferase I; ACO, acyl-CoA oxidase.
Fig. 1. Relationship between cDNA template concentration and ﬂuorescence
threshold cycle threshold (Ct). Linear regression of log concentration of
template vs. Ct . Template concentrations were equivalent to 200, 100, 50, 25,
and 12.5 ng RNA. Values are means of triplicate readings for the genes
acyl-CoA oxidase (ACO; F), hypoxanthine phosphoribosyltransferase (HPRT;
■ ), skeletal muscle carnitine palmitoyltransferase I (MCPT I; }), and liver
carnitine palmitoyltransferase I (LCPT I; ).
Table 2. Efﬁciency of ampliﬁcation of HPRT,
L CPT I, M CPT I, and ACO
Gene Slope r2 Efﬁciency* Average Ct
HPRT 3.60 0.99 1.89 22.42.00
LCPT I 3.21 1.00 2.04 23.52.43
MCPT I 3.80 0.99 1.82 21.51.33
ACO 2.68 0.99 2.34 24.31.73
*Efﬁciency calculated as E  101/slope. Average cycle threshold (Ct)
values are representative of starting template concentration equivalent to 100
ng RNA for control pigs.
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tively. Compared with control pigs, MCT supplemented pigs
weighed less (P  0.02), whereas no differences were detected
between control and cloﬁbrate or isoproterenol treatments.
Liver weights were 165 g (7), 228 g (10), 179 g (10), and
1 4 2g( 10) for control, cloﬁbrate, MCT, and isoproterenol-
supplemented pigs, respectively. Cloﬁbrate supplementation
increased liver weight by 38% (P  0.0001). There was no
difference in liver weight after MCT or isoproterenol supple-
mentation. The liver weight/body weight ratio was greater for
cloﬁbrate and MCT treatments (4.7  0.17 and 4.1  0.19,
respectively) than control pigs (3.3  0.13); however, there
was no difference between control and isoproterenol treatment
(3.0  0.18).
Total, mitochondrial, and peroxisomal ﬁrst-cycle -oxida-
tion rates of [1-14C]-palmitate, were similar between suckled
newborn pigs, control pigs, and pigs supplemented with MCT
or isoproterenol (Fig. 2; Table 3). Total and mitochondrial
oxidative capacities were increased 134 and 186%, respec-
tively, in liver homogenates from cloﬁbrate-supplemented pigs
compared with similar-age, control pigs (P  0.05; Fig. 2).
Peroxisomal -oxidation of [1-14C]-palmitate accounted for
41, 28, 39, and 43% of total -oxidative capacity for control,
cloﬁbrate, MCT, or isoproterenol-supplemented pigs, respec-
tively. Peroxisomal oxidation increased 60% with cloﬁbrate
supplementation (P  0.06); however, it represented less of the
total oxidation as a result of increased mitochondrial oxidative
capacity. Production of 14CO2 measured in liver homogenates
from cloﬁbrate, MCT, or isoproterenol-supplemented pigs did
not differ from control pigs, but the rate of 14C accumulation
into ASP from mitochondrial oxidation was 137% greater after
cloﬁbrate supplementation (P  0.001; Fig. 2).
Liver homogenates from control, cloﬁbrate, MCT, or iso-
proterenol-supplemented pigs exhibited no preference toward
metabolic fuel substrate as evidenced by similar rates of CO2
and ASP production with the addition of glucose to [1-14C]-
palmitate or palmitate to [1-14C]-glucose (Table 3). However,
in newborn pigs there was a 55% reduction in oxidative
products (CO2 plus ASP) when glucose was added to [1-14C]-
palmitate.
Differences in mean respiratory control ratios for isolated
mitochondria were not detected, Values were 3.0 for newborn,
control, and cloﬁbrate-treated pigs; and 3.7 and 3.1 for MCT
and isoproterenol-treated pigs, respectively. Supplementation
with cloﬁbrate increased both malonyl-CoA sensitive (CPT I)
and insensitive CPT activity by 64 and 105%, respectively
(Fig. 3). Supplementation with MCT or isoproterenol had no
Fig. 2. Rates of total, mitochondrial, and peroxisomal -oxidation (14CO2 and
[14C]-ASP accumulation); and mitochondrial [14C]-ASP production
(nmolh1mg protein1). Dietary treatments listed on the x-axis were fed
10–12 days before data collection. Bars represent means (n  5–9)  SE.
‡Different from control (P  0.01); comparison was made between similar
coded bars.
Table 3. Competitive oxidation of palmitate and glucose in liver homogenates of newborn pigs and pigs fed cloﬁbrate, MCT,
or isoproterenol: rates of carbon accumulation into oxidative products after incubations with [1-14C]-palmitate or [1-14C]-
glucose with or without the addition of unlabeled glucose or palmitate, respectively
[1-14C]-Palmitate [1-14C]-Palmitate  Glucose [1-14C]-Glucose [1-14C]-Glucose  Palmitate
nmol(hmg protein)1*
Newborn 23.93.4 10.83.4ax 27.83.4 21.33.4
Control 20.02.3 20.32.3b 21.62.3 21.72.3
Cloﬁbrate 46.92.6ax 45.32.6cx 18.02.6a 17.02.6
MCT 24.13.0 21.13.0b 27.73.0 27.03.0
Isoproterenol 16.72.8x 15.82.8abx 26.52.8 22.92.8
Substrates for oxidation were included in incubations as 1 mmol/l of [1-14C]-palmitate or palmitate and/or 5 mmol/l of [1-14C]-glucose or glucose. *For
palmitate-oxidative products, the carbon accumulated is the sum of CO2 plus acid-soluble products; for glucose-oxidative products, the carbon accumulated
represents CO2 only. abc Means within a column lacking a common superscript differ (P  0.05). xyz Means within a row lacking a common superscript differ
(P  0.05). MCT, medium-chain triglycerides.
Fig. 3. Malonyl-CoA-sensitive and malonyl-CoA-insensitive hepatic carnitine
palmitoyltransferase activity (CPT). Activity was measured at the end of a 10-
to 12-day feeding period of the dietary treatments listed on the x-axis. Total
activity is represented by summation of malonyl-CoA sensitive (CPT I) and
insensitive activities. Bars represent means  SE. Different letters (a,b) denote
signiﬁcant difference between dietary treatment for malonyl-CoA sensitive
CPT activity (P  0.05). Different letters (x,y,z) denote signiﬁcant difference
between dietary treatment for malonyl-CoA insensitive CPT activity (P 
0.05).
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mentation, the relative abundance of liver CPT I, skeletal
muscle CPT I, and ACO mRNA also was determined. As
assessed by real-time RT-PCR, effects of cloﬁbrate on relative
transcript amount of ACO or hepatic CPT I and skeletal muscle
CPT I in the respective tissues, were not detected (Fig. 4).
DISCUSSION
Studies have demonstrated that the rate of hepatic -oxida-
tion in young pigs is attenuated compared with other mammals
(1, 39). With fatty acids serving as the principal energy
substrate for oxidative metabolism during the suckling period
(13), the lower -oxidative capacities noted in this species may
indicate impaired nutrient handling. Consequently, improving
neonatal nutrition in the piglet hinges on understanding the fate
of fatty acids and their metabolic regulation by CPT I.
In this study, rates of palmitate oxidation did not differ
between the suckled newborn and 12-day-old pig, nor did CPT
I activity. Developmental changes in hepatic CPT activity have
been reported to occur within the initial 24 h of life in neonatal
pigs (5). Activity increases expeditiously after birth, and at 1
day of age, hepatic CPT activity is analogous to that measured
at 24 days of age (5). Equivalent rates of in vivo fatty acid
oxidation also have been reported between 1 and 7 days of age
in young pigs (31). However, studies suggest that -oxidative
capacity of pig liver homogenates increases approximately
fourfold between birth and 7 days of age (28). It was proposed
that postnatal increases in hepatic -oxidative capacity of the
liver occurs within the ﬁrst 24 h of life (34, 48). This postnatal
increase in fatty acid oxidation measured during the initial day
of life may be a consequence of increased cellular respiration
and not necessarily increased reliance on fatty acids for energy
(1, 34), as this period is marked by signiﬁcant mitochondrial
hyperplasia (29). Furthermore, postpartum peroxisomal prolif-
eration has been measured in the young pig (21) and may
further contribute to increased rates of hepatic fatty acid
oxidation.
At birth, 50% of piglet hepatic -oxidative capacity has
been ascribed to peroxisomal oxidation. This value increased
to 66% by 1 day of age and then decreased to 40% by 10 days
of age (47, 48). This is in agreement with the current study, in
which peroxisomal oxidation represented 41% of total oxida-
tion in 12-day-old control pigs. In contrast, Yu and colleagues
(48) reported a decrease in peroxisomal oxidation between 24 h
of age and 10 days of age, whereas, we did not detect differ-
ences in peroxisomal oxidation between the suckled newborn
and 12-day-old piglet. Although it is not known why these
differences occurred, piglets in the current study received a diet
formulated to contain 21% fat throughout the feeding period,
while Yu et al. (48) obtained piglets directly from the dam
before sampling. Fluctuations in milk fat content could have
contributed to differences in peroxisomal oxidation, as Yu et
al. (48) suggested that peroxisomal oxidation in pigs reﬂects
the availability of long-chain fatty acids. It is important to note
that although hepatic peroxisome number increases rapidly
after birth in rodents, peroxisomal oxidation represents only
10% of total oxidation (19). In the neonatal pig, the greater
contribution of peroxisomal oxidation to total oxidation may
provide an alternative route for catabolism of milk lipids (47,
48, 49), which by-passes regulation imposed at the level of
CPT I for mitochondrial oxidation.
Oxidative capacity of the liver after cloﬁbrate supplementa-
tion. Cloﬁbrate supplementation increased liver size 38%.
Similar observations have been noted in the rodent (18) and
attributed to increases in peroxisomal number and size (22).
Although neither peroxisomal hyperplasia nor hypertrophy
were determined in this study, Cheon and colleagues (9) did
not detect changes in peroxisomal nor hepatocyte morphology
after cloﬁbrate supplementation. It should be noted that in the
latter study, liver size was unchanged after cloﬁbrate supple-
mentation, contrary to our ﬁndings.
Only a modest effect (60% increase; P  0.06) on the rate
of peroxisomal oxidation was detected, as differences in ACO
mRNA approached signiﬁcance (P  0.08) with a 3.7-fold
induction. A previous study conducted in neonatal pigs (50)
suggested a more robust effect after cloﬁbrate supplementa-
tion, resulting in a 2.7-fold increase in peroxisomal oxidation.
This discrepancy may be a result of methodology used to
measure peroxisomal oxidation. While in the current study,
peroxisomal oxidation was assessed by rotenone- and antimy-
cin-insensitive -oxidation of [1-14C]-palmitate, which mea-
sures only the initial round of -oxidation, Yu and colleagues
(50) used the palmitoyl-CoA-dependent, KCN-insensitive re-
duction of NAD, which quantitates all cycles of peroxisomal
-oxidation.
In comparison to the effects observed in the rat, where
hypolipidemic drugs have induced a 20-fold increase in per-
oxisomal oxidation (22), the effects of cloﬁbrate supplemen-
tation are attenuated in the pig. It is generally accepted that
peroxisome proliferator-activated receptor (PPAR) mediates
the effects of cloﬁbrate. In humans, lower transcript amounts of
ACO have been attributed to lower hepatic expression of
PPAR (2, 37). Although hepatic PPAR mRNA is abundant
in 5-wk-old pigs (9, 46), expression is reportedly low in certain
breeds of neonatal pigs (46). Furthermore, the presence of an
alternatively spliced PPAR isoform, which lacks the ligand-
binding domain could contribute to the lower responsiveness of
the pig to cloﬁbrate (46).
Despite only a modest increase in peroxisomal oxidation,
total oxidation increased approximately twofold as a result of
greater mitochondrial oxidative rates. Cloﬁbrate treatment in
rats increases hepatic mitochondrial number (20) and mito-
chondrial oxidation (25). Although mitochondrial mass was
Fig. 4. Relative hepatic ACO, LCPT I, and MCPT I mRNA amounts.
Amounts of mRNA for control pigs are set as 100%, and data are reported as
% change for cloﬁbrate-supplemented pigs relative to control pigs. Data were
corrected for changes in reference gene expression, according to Pfafﬂ (42).
Bars represent means (n  4–5)  SE; P  0.08, 0.16, and 0.3 for ACO,
LCPT I, and MCPT I, respectively, for cloﬁbrate-supplemented vs. control
pigs.
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number is correlated with increased rates of mitochondrial
oxidation (30) and could account for increased rates of -ox-
idation measured. Alternatively, data in rodents suggest that
cloﬁbrate treatment increases CPT I expression and activity (8,
25). Indeed, concomitant with increased mitochondrial ﬂux of
palmitate, CPT I activity was increased; however, we failed to
detect a difference in hepatic mRNA abundance. Likewise, an
effect of cloﬁbrate supplementation on expression of skeletal
muscle CPT I was not detected. If the effects of cloﬁbrate on
CPT I expression are mediated via PPAR, then the low
abundance of PPAR in the liver, which also has been ob-
served in piglet skeletal muscle (46), may have contributed to
the lack of CPT I upregulation in the current study. Recently,
evidence has emerged, which supports the role of PPAR in
mediating the effects of cloﬁbrate in young pigs (9). Contrary
to our ﬁndings, Cheon and colleagues (9) reported a ﬁvefold
induction in hepatic CPT I following cloﬁbrate supplementa-
tion, coincident with elevated mRNA abundance of PPAR.
Research indicates changes in PPAR mRNA with age (45)
could account for the differences noted.
Oxidation of palmitate and glucose after MCT feeding. The
use of MCT as an alternative metabolic fuel for the neonatal
pig has been researched extensively in light of the pigs’ ability
to digest, absorb, and utilize medium-chain fatty acids released
from this energy source (36). Compared with long-chain fatty
acids, the rate and extent of MCT utilization was reported to be
three- and four-fold greater, respectively (17). Greater oxida-
tive ﬂux of carbon has been measured in cultured porcine
hepatocytes after MCT incubation (34); however, we were
unable to detect differences in palmitate oxidation or CPT I
activity after MCT feeding. Data collected from rodents also
suggests that MCT feeding has no effect on subsequent ﬂux of
long-chain fatty acids through -oxidation (40). Furthermore,
ﬁnal weight of pigs receiving MCT was lower than control
pigs. It has been reported that although the piglet can use MCT,
growth is not improved (24).
It is interesting to note that MCT supplementation had no
deleterious effects on peroxisomal oxidation. Medium-chain
fatty acids are poor substrates for oxidation by the peroxisome,
because of the lower afﬁnity of acyl-CoA oxidase toward acyl
substrates of eight or fewer carbons (16). Furthermore, perox-
isomal oxidative capacity is responsive to high-fat feeding of
long-chain fatty acids (32). Although suckling is important for
the establishment of optimal peroxisomal -oxidative capaci-
ties (48, 49), it appears that maintaining high rates of peroxi-
somal -oxidation is not dependent on a continual source of
long-chain fatty acids in the young pig.
Effects of isoproterenol on palmitate oxidation. This study is
the ﬁrst to present the effects of a -agonist on hepatic fatty
acid oxidation in neonatal pigs. In vitro studies in older pigs
have shown a decrease in lipogenesis and an increase in
lipolysis when porcine adipose tissue explants were incubated
with isoproterenol (a 1/2 agonist) (41). The effect on lipol-
ysis also has been observed in vivo after isoproterenol infusion
(30). Furthermore, isoproterenol has increased circulating fatty
acids twofold by 7 days of age in piglets (44). It was hypoth-
esized that a putative effect of isoproterenol would be en-
hanced -oxidation as a consequence of increased circulating
fatty acids resulting from isoproterenol’s known effects on
lipolysis and lipogenesis. However, differences in rates of
palmitate oxidation or hepatic CPT I activity were not detected
in this study.
First-pass metabolism by the liver may limit the bioavail-
ability of isoproterenol when fed as previously suggested (12).
In rodents, isoproterenol stimulated lipolysis in isolated adipo-
cytes; however, no effects on lipolysis were observed after the
-agonist was fed (12). Alternatively, desensitization and/or
downregulation of the -adrenergic receptor after continual
exposure of the ligand are a known mode of regulation (23).
Data indicate that continual exposure to -agonists postpartum
promotes hepatic desensitization of the receptor (4). The 12-
day exposure period to isoproterenol in this study may have
contributed to the lack of effect via receptor desensitization
which would have abated any cellular response.
In conclusion, although nutraceutical or pharmacological
beneﬁts of isoproterenol or MCT were not evident from ﬁnd-
ings reported in the current study, the use of cloﬁbrate for
dietary intervention may provide a means of reducing neonatal
morbidity and mortality in piglets. Studies implicating CPT I in
reduced mitochondrial fatty acid ﬂux suggest that increasing
CPT I activity may promote increased -oxidation, which is
essential to the development of the newborn pig. Increased
mitochondrial oxidation after cloﬁbrate supplementation was
coincident with increased CPT I in the current study; however,
the effect did not appear to be due to induction of CPT I
mRNA. In neonatal pigs, the effect of cloﬁbrate is primarily
through enhancement of mitochondrial oxidation, as the al-
ready substantial rates of peroxisomal oxidation were not
further increased. It has been suggested that the peroxisomal
oxidative system provides an alternate route for the catabolism
of fatty acids (48), as peroxisomal oxidation appears to play a
substantial role in the piglets’ ability to adapt to the change in
primary energy source encountered at birth.
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